1. Home
  2. TCBK vs RLAY Comparison

TCBK vs RLAY Comparison

Compare TCBK & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriCo Bancshares

TCBK

TriCo Bancshares

HOLD

Current Price

$47.04

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$10.13

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCBK
RLAY
Founded
1975
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
TCBK
RLAY
Price
$47.04
$10.13
Analyst Decision
Buy
Strong Buy
Analyst Count
5
6
Target Price
$53.80
$15.67
AVG Volume (30 Days)
150.2K
2.3M
Earning Date
04-23-2026
01-01-0001
Dividend Yield
3.04%
N/A
EPS Growth
6.94
31.78
EPS
3.70
N/A
Revenue
$53,445,000.00
$15,355,000.00
Revenue This Year
$12.03
N/A
Revenue Next Year
$4.47
$396.00
P/E Ratio
$12.80
N/A
Revenue Growth
4.12
53.44
52 Week Low
$35.20
$1.78
52 Week High
$53.18
$11.49

Technical Indicators

Market Signals
Indicator
TCBK
RLAY
Relative Strength Index (RSI) 38.45 59.61
Support Level $46.55 $9.06
Resistance Level $51.11 $11.43
Average True Range (ATR) 1.36 0.78
MACD -0.16 0.03
Stochastic Oscillator 21.22 53.28

Price Performance

Historical Comparison
TCBK
RLAY

About TCBK TriCo Bancshares

TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: